Journal of Ophthalmic and Vision Research

ISSN: 2008-322X

The latest research in clinical ophthalmology and the science of vision.

Diffuse Pigment Release in a Patient Undergoing Tumor-Infiltrating Lymphocyte Immunotherapy for Acral Malignant Melanoma

Published date: Jul 23 2023

Journal Title: Journal of Ophthalmic and Vision Research

Issue title: July–September 2023, Volume 18, Issue 3

Pages: 339–341

DOI: 10.18502/jovr.v18i3.13783

Authors:

Madison Kerley - madison.kerley@louisville.edu

Niloofar Piri

Aparna Ramasubramanian

Abstract:

This is a Photo Essay and does not have an abstract. Please download the PDF or view the article in HTML.

References:

1. Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: Incidence and survival patterns in the United States, 1986–2005. Arch Dermatol 2009;145:427–434.

2. Nakamura Y, Fujisawa Y. Diagnosis and management of acral lentiginous melanoma. Curr Treat Options Oncol 2018;19:42.

3. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractor metastatic melanoma. J Clin Oncol 2005;23:2346–2357.

4. Yeh S, Karne NK, Kerkar SP, Heller CK, Palmer DC, Johnson LA, et al. Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology 2009;116:98–989.

5. Sakata VM, da Silva FT, Hirata CE, de Carvalho JF, Yamamoto JH. Diagnosis and classification of VogtKoyanagi-Harada disease. Autoimmun Rev 2014;13:550– 555.

Download
HTML
Cite
Share
statistics

506 Abstract Views

425 PDF Downloads